{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:19:02Z","timestamp":1777983542268,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cardfail.2026.03.020","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:59:20Z","timestamp":1774972760000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Invasive Assessment of Coronary Microvascular Dysfunction in Patients With Wild-Type Transthyretin Amyloid Cardiomyopathy"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8496-3784","authenticated-orcid":false,"given":"DAISUKE","family":"SUNOHARA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4630-9815","authenticated-orcid":false,"given":"YASUSHI","family":"UEKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASATOSHI","family":"MINAMISAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MITSUTO","family":"SATO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KOKI","family":"FUJIMORI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AYUMU","family":"NAGAE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKENORI","family":"AOKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEN","family":"NISHIKAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHO","family":"SUZUKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TADASHI","family":"ITAGAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUKI","family":"YAMAMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOSHITERU","family":"OKINA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIDETOMO","family":"NOMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KOJI","family":"YOSHIE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAMON","family":"KATO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TATSUYA","family":"SAIGUSA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SOICHIRO","family":"EBISAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOSHIKI","family":"SEKIJIMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KOICHIRO","family":"KUWAHARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2026.03.020_bib0001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacc.2019.04.054","article-title":"Association of carpal tunnel syndrome with amyloidosis, heart failure, and adverse cardiovascular outcomes","volume":"74","author":"Fosb\u00f8l","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0002","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0003","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/ehf2.15016","article-title":"Transthyretin amyloid cardiomyopathy: literature review and red-flag symptom clusters for each cardiology specialty","volume":"12","author":"Izumiya","year":"2025","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0004","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC State-of-the-Art Review","volume":"78","author":"Del Buono","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0005","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jchf.2014.03.009","article-title":"Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis","volume":"2","author":"Dorbala","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0006","article-title":"Concomitant amyloidosis is the primary cause of endothelial and coronary microvascular dysfunction in carpal tunnel syndrome","volume":"41","author":"\u0130rgi","year":"2024","journal-title":"Am Heart J Plus"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocmr.2024.101134","article-title":"Assessing microvascular dysfunction and predicting long-term prognosis in patients with cardiac amyloidosis by cardiovascular magnetic resonance quantitative stress perfusion","volume":"27","author":"Tang","year":"2025","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0008","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1007\/s10278-024-01179-7","article-title":"Myocardial transit time mapping by CMR: a novel indicator of microcirculatory dysfunction in cardiac amyloidosis","volume":"37","author":"Yang","year":"2024","journal-title":"J Imaging Inform Med"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0009","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1253\/circj.CJ-20-0910","article-title":"JCS\/JHFS 2018 Guideline on the diagnosis and treatment of cardiomyopathies","volume":"85","author":"Kitaoka","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0011","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jacc.2016.05.067","article-title":"Standardization of fractional flow reserve measurements","volume":"68","author":"Toth","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0012","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jcin.2020.12.037","article-title":"Basics of coronary thermodilution","volume":"14","author":"Candreva","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0013","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1253\/circj.CJ-22-0779","article-title":"JCS\/CVIT\/JCC 2023 Guideline Focused Update on Diagnosis and Treatment of Vasospastic Angina (Coronary Spastic Angina) and Coronary Microvascular Dysfunction","volume":"87","author":"Hokimoto","year":"2023","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0014","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1161\/CIRCULATIONAHA.119.041595","article-title":"Coronary microvascular dysfunction is associated with myocardial ischemia and abnormal coronary perfusion during exercise","volume":"140","author":"Rahman","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020464","article-title":"Risk stratification of patients with nonobstructive coronary artery disease using resistive reserve ratio","volume":"10","author":"Toya","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0016","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jacc.2021.08.017","article-title":"Microvascular resistance reserve for assessment of coronary microvascular function: JACC Technology Corner","volume":"78","author":"De Bruyne","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0017","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"99mTc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imag"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024717","article-title":"Correlation between cardiac images, biomarkers, and amyloid load in wild-type transthyretin amyloid cardiomyopathy","volume":"11","author":"Morioka","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0019","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Meth"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0020","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010805","article-title":"Coronary microvascular dysfunction in patients with heart failure: characterization of patterns in HFrEF versus HFpEF","volume":"17","author":"Paolisso","year":"2024","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0021","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamacardio.2021.1825","article-title":"Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction","volume":"6","author":"Rush","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0022","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF","volume":"39","author":"Shah","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0023","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1016\/j.jacc.2020.03.051","article-title":"Physiological stratification of patients with angina due to coronary microvascular dysfunction","volume":"75","author":"Rahman","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0024","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1253\/circj.CJ-24-0733","article-title":"Long-term effect of tafamidis on clinical parameters and prognostic predictors in patients with transthyretin amyloid cardiomyopathy","volume":"89","author":"Kuyama","year":"2025","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0025","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00392-019-01559-y","article-title":"A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis","volume":"109","author":"Kreusser","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0026","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jcmg.2014.03.002","article-title":"Noninvasive risk stratification of patients with transthyretin amyloidosis","volume":"7","author":"Kristen","year":"2014","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0027","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/ehjci\/jez180","article-title":"Diagnostic score of cardiac involvement in AL amyloidosis","volume":"21","author":"Nicol","year":"2020","journal-title":"Eur Heart J Cardiovasc Imag"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0028","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ehf2.12203","article-title":"Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis","volume":"5","author":"Takashio","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0029","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaccao.2024.10.013","article-title":"Biomarkers to predict abnormal technetium-99m pyrophosphate scans in patients with suspected transthyretin amyloidosis","volume":"7","author":"De Michieli","year":"2025","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.cardfail.2026.03.020_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaccao.2023.12.006","article-title":"Cardiac troponin in patients with light chain and transthyretin cardiac amyloidosis: JACC: CardioOncology State-of-the-Art Review","volume":"6","author":"De Michieli","year":"2024","journal-title":"JACC CardioOncol"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916426001855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916426001855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:21:25Z","timestamp":1777980085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916426001855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":30,"alternative-id":["S1071916426001855"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2026.03.020","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive Assessment of Coronary Microvascular Dysfunction in Patients With Wild-Type Transthyretin Amyloid Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2026.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}